Klotho Neurosciences (KLTOW) Financials

Balance sheets

Sep 30, 2024Jun 30, 2024Sep 30, 2023Jun 30, 2023

Total Assets

$2.5 M(-25.5%)$3.3 M-$2.3 M

Current Assets

$154.6 K(-84.5%)$999.8 K-$41.4 K

Non Current Assets

$2.3 M(0%)$2.3 M-$2.2 M

Total Liabilities

$1.0 M(-79.3%)$4.9 M-$1.5 M

Current Liabilities

$982.4 K(+9.3%)$898.6 K-$1.5 M

Long Term Liabilities

$21.2 K(-99.5%)$4.0 M-$0.0

Shareholders Equity

$1.5 M(+194.2%)-$1.6 M-$742.3 K

Book Value

-$849.0 K(+78.0%)-$3.9 M--$1.5 M

Working Capital

-$827.8 K(-917.4%)$101.3 K--$1.5 M

Cash And Cash Equivalents

$50.9 K(-94.0%)$845.3 K-$40.4 K

Accounts Payable

$271.1 K(+697.7%)$34.0 K-$174.3 K

Accounts Receivable

----

Short Term Debt

$151.0 K(+387.1%)$31.0 K-$1.3 M

Long Term Debt

-$3.9 M--

Total Debt

$151.0 K(-96.2%)$3.9 M-$1.3 M

Debt To Equity

0.1(+104.0%)-2.5-1.8

Current Ratio

0.2(-85.6%)1.1-0.0

Quick Ratio

----

Inventory

----

Retained Earnings

-$8.5 M(-53.5%)-$5.5 M--$3.7 M

PB Ratio

----

Income statements

Sep 30, 2024Jun 30, 2024Sep 30, 2023Jun 30, 2023

EPS

----

TTM EPS

----

Revenue

$0.0(0%)$0.0(0%)$0.0(0%)$0.0

TTM Revenue

$0.0(0%)$0.0(0%)$0.0(0%)$0.0

Total Expenses

$2.9 M(+625.7%)$395.6 K(+219.7%)$123.7 K(-49.3%)$244.3 K

Operating Expenses

$2.9 M(+625.7%)$395.6 K(+219.7%)$123.7 K(-49.3%)$244.3 K

Cost Of Goods Sold

----

TTM Cost Of Goods Sold

----

Gross Profit

----

TTM Gross Profit

----

Gross Margin

----

Operating Profit

-$2.9 M(-625.7%)-$395.6 K(-219.7%)-$123.7 K(+49.3%)-$244.3 K

TTM Operating Profit

-$3.3 M(-529.0%)-$519.3 K(-41.1%)-$368.0 K(-50.7%)-$244.3 K

Operating Margin

----

Net Income

-$3.0 M(-555.3%)-$451.6 K(-213.4%)-$144.1 K(+45.5%)-$264.4 K

TTM Net Income

-$3.4 M(-472.6%)-$595.8 K(-45.8%)-$408.5 K(-54.5%)-$264.4 K

Net Margin

----

EBIT

-$2.9 M(-567.6%)-$436.6 K(-252.8%)-$123.7 K(+49.3%)-$244.2 K

TTM EBIT

-$3.4 M(-498.1%)-$560.3 K(-52.3%)-$368.0 K(-50.7%)-$244.2 K

EBITDA

-$3.0 M(-644.7%)-$396.9 K(-220.8%)-$123.7 K(+49.3%)-$244.2 K

TTM EBITDA

-$3.4 M(-543.9%)-$520.6 K(-41.5%)-$368.0 K(-50.7%)-$244.2 K

Selling, General & Administrative Expenses

$2.9 M(+625.7%)$395.6 K(+219.7%)$123.7 K(-49.3%)$244.3 K

TTM SGA

$3.3 M(+529.0%)$519.3 K(+41.1%)$368.0 K(+50.7%)$244.3 K

Depreciation And Amortization

----

TTM D&A

----

Interest Expense

$45.0 K(+198.4%)$15.1 K(-26.1%)$20.4 K(+1.1%)$20.2 K

TTM Interest Expense

$60.0 K(+69.3%)$35.4 K(-12.6%)$40.5 K(+101.1%)$20.2 K

Income Tax

$0.0(0%)$0.0(0%)$0.0(0%)$0.0

TTM Income Tax

$0.0(0%)$0.0(0%)$0.0(0%)$0.0

PE Ratio

----

PS Ratio

----

Cashflow statements

Sep 30, 2024Jun 30, 2024Sep 30, 2023Jun 30, 2023

Cash From Operations

-$1.1 M-$18.0 K-

TTM CFO

-$1.1 M-$18.0 K-

Cash From Investing

$0.0--$56.3 K-

TTM CFI

$0.0--$56.3 K-

Cash From Financing

$278.5 K-$0.0-

TTM CFF

$278.5 K-$0.0-

Free Cash Flow

-$1.1 M--$38.3 K-

TTM FCF

-$1.1 M--$38.3 K-

CAPEX

--$56.3 K-

TTM CAPEX

--$56.3 K-

Dividends Paid

----

TTM Dividends Paid

----

TTM Dividend Per Share

----

TTM Dividend Yield

----

Payout Ratio

----